Overview

Different Dyskinesias in Parkinson's Disease and Their Relation to Levodopa Pharmacokinetics

Status:
Completed
Trial end date:
2008-05-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to study different kinds of dyskinesias in advanced Parkinson's disease appearing at different levels of levodopa infusion dose. The hypothesis is that different dyskinesias (dystonia, chorea) correlate to different levels of levodopa concentrations, as detected in plasma.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Uppsala University
Collaborators:
Swedish Parkinson's Disease Foundation
Swedish Society for Medical Research
Treatments:
Carbidopa
Carbidopa, levodopa drug combination
Levodopa
Criteria
Inclusion Criteria:

- Clinical diagnosis of idiopathic Parkinson's disease

- Ongoing treatment with Duodopa

- Occurrence of dyskinesias, difficult to manage

- Age 30-90 years

- Hoehn & Yahr stage 3-5 at worst

Exclusion Criteria:

- Treatment with dopamine agonist or glutamate antagonist

- Dementia

- Psychosis

- Treatment with typical neuroleptics